Sinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express03-16 16:41

Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC.

The agenda includes:

1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.

2. Considering the publication of those results.

3. Deliberating a recommendation on the payment of a final dividend, if any.

Board composition at the date of the announcement (16 March 2026) is as follows:

• Executive Directors: Huang Xiangbin (Chairman), Lei Shifeng, Huang Zhijian • Non-executive Director: Jing Huan • Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang, Bai Zhizhong

The company will release additional disclosures after the board meeting concludes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123263759?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123263759","market":"hk","top_or_hot":-1,"title":"Sinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC.</p>\n<p>The agenda includes:</p>\n<p>1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.</p>\n<p>2. Considering the publication of those results.</p>\n<p>3. Deliberating a recommendation on the payment of a final dividend, if any.</p>\n<p>Board composition at the date of the announcement (16 March 2026) is as follows:</p>\n<p>• Executive Directors: Huang Xiangbin (Chairman), Lei Shifeng, Huang Zhijian  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang, Bai Zhizhong</p>\n<p>The company will release additional disclosures after the board meeting concludes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC.</p>\n<p>The agenda includes:</p>\n<p>1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.</p>\n<p>2. Considering the publication of those results.</p>\n<p>3. Deliberating a recommendation on the payment of a final dividend, if any.</p>\n<p>Board composition at the date of the announcement (16 March 2026) is as follows:</p>\n<p>• Executive Directors: Huang Xiangbin (Chairman), Lei Shifeng, Huang Zhijian  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang, Bai Zhizhong</p>\n<p>The company will release additional disclosures after the board meeting concludes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06833","symbol_name":"兴科蓉医药","start_time":0,"source_url":"","article_id":"1123263759","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123263759","pubTimestamp":1773650468,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC. The agenda includes: 1. Reviewing and approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06833":"兴科蓉医药"},"translate_title":"新科制药(06833)定于2026年3月26日召开董事会批准2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06833":1},"content_text":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC.\nThe agenda includes:\n1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.\n2. Considering the publication of those results.\n3. Deliberating a recommendation on the payment of a final dividend, if any.\nBoard composition at the date of the announcement (16 March 2026) is as follows:\n• Executive Directors: Huang Xiangbin (Chairman), Lei Shifeng, Huang Zhijian  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang, Bai Zhizhong\nThe company will release additional disclosures after the board meeting concludes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123263759","isCrawlerRequest":true}